Publication:
A type I interferon-mitochondrial axis regulates efferocytosis and interferon-stimulated gene induction in macrophages.

dc.contributor.authorDunphy, Gillian
dc.contributor.authorAdán-Barrientos, Irene
dc.contributor.authorFernández-Delgado, Irene
dc.contributor.authorVillarroya-Beltri, Carolina
dc.contributor.authorHeras-Murillo, Ignacio
dc.contributor.authorMoya-Ruiz, Elena
dc.contributor.authorSánchez-Álvarez, Miguel
dc.contributor.authorJarit-Cabanillas, Aitor
dc.contributor.authorDel Pozo, Miguel A
dc.contributor.authorGuerra, Susana
dc.contributor.authorSánchez-Madrid, Francisco
dc.contributor.authorSancho, David
dc.date.accessioned2026-03-20T10:21:43Z
dc.date.available2026-03-20T10:21:43Z
dc.date.issued2026-02-10
dc.description.abstractMacrophage metabolism is intricately linked to cellular function. Contrasting with Toll-like receptor (TLR) stimulation, cytosolic nucleic acid sensing induced a decrease in mitochondrial membrane potential (MMP) while maintaining mitochondrial respiration. Interferon α/β (IFN-I) receptor (IFNAR) signaling was necessary and sufficient for this metabolic response. IFNAR signaling induced interferon-stimulated gene 15 (ISG15) expression and ISGylation of mitochondrial proteins, including subunits of mitochondrial complex V, increasing ATP production and decreasing MMP, thus enhancing macrophage efferocytic capacity. Moreover, the IFNAR-ISG15-mediated drop in MMP activated the mitochondrial protease OMA1, inducing mitochondrial fission and decreasing endoplasmic reticulum-mitochondria communication, thus dampening IFN-stimulated gene (ISG) induction. Loss of ISG15 or OMA1 enhanced histone acetylation and ISG induction upon IFN-I stimulation, in a manner dependent on mitochondrial calcium uptake. This increase in ISG induction provided protection against acute viral infections. These data indicate that IFNAR-ISG15 signaling boosts efferocytosis while limiting ISG induction, thereby promoting the resolution of inflammation.
dc.description.peerreviewed
dc.description.tableofcontentsWe thank the D.S. laboratory for scientific discussions and Professor Jesús Vázquez and Dr. Enrique Calvo of the CNIC Proteomics Service for their expertise. The D.S. laboratory received support from the CNIC; the Ministerio de Ciencia, Innovación y Universidades (MICIU) (PID2022-137712OB-I00, CPP2021- 008310, CPP2022-009762, and CPP2024-011365); MICIU/AEI/10.13039/501100011033 Agencia Estatal de Investigación, Unión Europea NextGenerationEU/PRTR; Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); the Scientific Foundation of the Spanish Association Against Cancer (AECCPRYGN246642SANC); Worldwide Cancer Research (WWCR-25-0080); Fundacio´ n CRIS contra el ca´ ncer (excellence2025_03); the European Union (ERC-2023-PoC GA-101158245-ImnovAth); and the ‘‘La Caixa’’ Foundation (LCF/PR/HR23/52430012 and LCF/PR/HR22/52420019). M.A.d.P. acknowledges support from the Spanish Ministry of Science, Innovation & Universities (MICIU)/Agencia Estatal de Investigacio´ n (AEI)/FEDER (PID2023-146414OBI00/AEI/10.13039/501100011033); from ERDF/EU; and from the Comunidad de Madrid (TecNanoBio-CM, ref. TEC-2024/TEC-158). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 892965. G.D. is supported by a European Molecular Biology Organization Long-term Fellowship ALTF 379-2019. I.A.-B. is supported by a Beca de Formación del Profesorado Universitario (FPU) fellowship (FPU18/05752). I.H.-M. is supported by a La Caixa INPhINIT fellowship (ID 100010434, fellowship code: LCF/BQ/IN17/11620074). E.M.-R. is a recipient of support from the Comunidad Autonoma de Madrid (PIPF-2023/SAL-GL-29932). A.J.-C. is supported by a Beca de Formacio´ n del Profesorado Universitario (FPU) fellowship (FPU18/05434). M.S.-A. is supported by the MICIU (RYC2020-029690-I and PID2021-128106NA-I00). Flow cytometry was conducted at the CNIC Flow Cytometry Unit. Microscopy was conducted at Microscopy & Dynamic Imaging, CNIC. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICIU, and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (CEX2020-001041-S funded by MICIU/AEI /10.13039/501100011033).
dc.format.number2
dc.format.page306-321
dc.format.volume59
dc.identifier.citationImmunity. 2026 Feb 10;59(2):306-321.
dc.identifier.journalImmunity
dc.identifier.pubmedID41610845
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27339
dc.language.isoeng
dc.publisherCell Press
dc.relation.isreferencedbyPubMed
dc.relation.publisherversion10.1016/j.immuni.2025.12.010
dc.repisalud.institucionCNIC
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectefferocytosis
dc.subjectinterferon-stimulated genes
dc.subjectmacrophage
dc.subjectmetabolism
dc.subjectmitochondrial endoplasmic reticulum contacts
dc.subjectmitochondrial fission
dc.subjectmitochondrial membrane potential
dc.subjectoxidative phosphorylation
dc.subjecttype I interferon
dc.subjectviral infection
dc.titleA type I interferon-mitochondrial axis regulates efferocytosis and interferon-stimulated gene induction in macrophages.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
A type I interferon-mitochondrial_Immunity_2026.pdf
Size:
8.07 MB
Format:
Adobe Portable Document Format